Physician profile
William E Jones
NPI 1952583148
$7,969.92
in general payments reported to CMS, 2019-2025
15 companies · $4,819 in 2025
The $4,819 reported for 2025 was more than what 95% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,500 · 2021: $129 · 2022: $174 · 2024: $348 · 2025: $4,819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,300 · Food and Beverage: $1,867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,300.00 |
| Food and Beverage | $1,867.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,729.30 | 2024-2025 | |
| Canon Medical Systems USA, INC. | $2,500.00 | 2019 | |
| Teleflex LLC | $644.11 | 2024-2025 | Barrigel |
| Bioprotect Medical, INC. | $182.17 | 2025 | Bioprotect Balloon Implant System |
| Elekta, INC. | $173.96 | 2022 | |
| Progenics Pharmaceuticals, INC. | $150.52 | 2025 | |
| Novocure INC. | $128.92 | 2021 | |
| Urogen Pharma, INC. | $124.99 | 2025 | |
| Myriad Genetic Laboratories, INC. | $103.68 | 2024-2025 | Prolaris |
| Sumitomo Pharma America, INC. | $74.93 | 2024-2025 | Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $49.03 | 2025 | |
| Boston Scientific Corporation | $43.34 | 2025 | Spaceoar Vue System - 10ml |
| Telix Pharmaceuticals | $33.05 | 2025 | Illuccix |
| Pfizer INC. | $17.86 | 2025 | |
| Siemens Medical Solutions USA, INC. | $14.06 | 2025 | Truebeam |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.